Trial Profile
A Prospective Single Arm Exploratory Clinical Research on the Efficacy and Safety of KN035 in Patients With Advanced Multiple Primary Tumors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Envafolimab (Primary)
- Indications Colorectal cancer; Intestinal cancer; Solid tumours
- Focus Therapeutic Use
- 28 Nov 2019 Status changed from not yet recruiting to recruiting.
- 24 Aug 2018 New trial record